PATENT CLAIM ANALYSIS

Application Number: 15962770
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-03
Patent Classification: ["514", "011700"]

Abstract:
The present invention refers to a pharmaceutical composition for use in the treatment of a neurodegenerative disease.

Claim (Index 5):
The method according to  claim 4 , wherein the composition attenuates neuronal loss caused by ischemia.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 91.0
- Lexical Diversity: 1.05882
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15146255', '13602913', '13594313', '12317042', '15503636']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.63665884181227
- 35 USC 102 Novelty (BERT): 0.6235205191537319
- Combined Prediction Score: 0.6353450095464162
- Mean Citation Score: 418.68225600000005
- Max Citation Score: 669.88635
- Similarity Product: 470.3545830561608

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test